Bone morphogenetic protein 2 suppresses the transformed phenotype and restores actin microfilaments of human lung carcinoma A549 cells

Oncology Reports

Volumn 5, Issue 5, 1998, Pages 1137-1140

  Tada, A ^a   Nishihara, T ^b   Kato, H ^b  

^a Chiba City Public Health Office   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Bone morphogenetic protein; Cytoskeleton; Transformation; Transforming growth factor type

Indexed keywords

ACTIVIN A; BONE MORPHOGENETIC PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ACTIN FILAMENT; ARTICLE; CARBOXY TERMINAL SEQUENCE; CARCINOMA CELL; CELL DIFFERENTIATION; CELL GROWTH; CELL TRANSFORMATION; COLONY FORMING UNIT; CYTOSKELETON; GROWTH INHIBITION; HUMAN; HUMAN CELL; LUNG CARCINOMA; MICROFILAMENT; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FAMILY; TUMOR GROWTH;

EID: 0031855504     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.5.5.1137     Document Type: Article

References (26)

1. Massague J: The transforming growth factor β family. Annu Rev Cell Biol 6: 597-641, 1990.
2. Ozkarynak E, Schinegelsberg PN, Jin DF, Cliffor GM, Warren FD, Drier EA and Opperman H: Osteogenic protein-2. J Biol Chem 267: 20220-20227, 1992.
3. Basler K, Edlund T, Jessell TM and Yamada T: Control of cell pattern in the neural tube: regulation of cell differentiation by dorsalin-1, a novel TGFβ family member. Cell 73: 687-702, 1993.
4. Paralkar VM, Weeks BS, Yu M, Kleinmann HK and Reddi AH: Recombinant human bone morphogenetic protein 2B stimulates PC 12 cell differentiation: potentiation and binding to type IV collagen. J Cell Biol 119: 1721-1728, 1992.
5. Lee S-J: Expression of growth/differentiation factor 1 in the nervous system: conservation of a bicistronic structure. Proc Natl Acad Sci USA 88: 4250-4254, 1991.
6. Lyons KM, Jones CM and Hogan BLM: The DVR gene family in embryonic development. Trends Genet 7: 408-412, 1991.
7. McPherron AC and Lee S-J: GDF-3 and GDF-9: two new members of the transforming growth factor-β superfamily containing a novel pattern of cysteines. J Biol Chem 268: 3444-3449, 1993.
8. Wozne J, Rosen MV, Celeste SJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM and Wang EA: Novel regulation of bone formation: molecular clones and activities. Science 242: 1528-1534, 1988.
9. Luyten FP, Cunningham NS, Ma S, Muthukumaran N, Hammonds RG, Nevins WB and Reddi AH: Purification and partial amino acid sequence of osteogenin, a protein initiating bone differentiation. J Biol Chem 264: 13377-13380, 1989.
10. Sampath TK, Coughlin JH, Whetstone RM, Banach D, Corbett C, Ozkaynak E, Oppermann H and Ruege D: Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2 A, two members of the transforming factor-β superfamily. J Biol Chem 265: 13198-13205, 1990.
11. Ozkaynak E, Rueger D, Drier EA, Corbett C, Ridge RJ, Sampath TK and Oppermann T: OP-1 cDNA encodes an osteogenic protein in the TGFβ family. EMBO J 9: 2085-2093, 1990.
12. Vukicevic S, Luyten FP and Reddi AH: Stimulation of the expression of the osteogenic and chondrogenic phenotypes in vitro by osteogenin. Proc Natl Acad Sci USA 86: 8793-8797, 1989.
13. Vukicevic S, Luyten FP and Reddi AH: Stimulation of the expression of osteogenic and chondrogenic phenotypes in vitro by osteogenin. Biochem Biophys Res Commun 166: 750-756, 1990.
14. Perides G, Safran RM, Downing LA and Charness ME: Regulation of neural cell adhesion molecule and L1 by the transforming growth factor-β superfamily. J Biol Chem 269: 765-770, 1994.
15. Serra R, Verderama MF and Isom HC: Transforming growth factor-β1 partially suppresses the transformed phenotype of ras transformed hepatocytes. Cell Growth Differ 3: 693-704, 1992.
16. Serra R, Carbonetto S, Lord M and Isom HC: Transforming growth factor β1 suppresses transformation in hepatocytes by regulating α1, β1 integrin expression. Cell Growth Differ 5: 509-517, 1994.
17. Tada A, Kato H, Takenaga K and Hasegawa S: Transforming growth factor β1 increases the expressions of high molecular weight tropomyosin isoforms and vinculin and suppresses the transformed phenotypes in human lung carcinoma cells. Cancer Lett 121: 31-37, 1997.
18. Murata M, Eto Y, Shibai H, Sakai M and Muramatsu M: Erythroid differentiation factor is encoded by the same mRNA as that of the inhibin βA chain. Proc Natl Acad Sci USA 85: 2434-2438, 1988.
19. Prochniewicz-Nakayama E, Yanagida T and Oosawa F: Studies on conformation of F-actin in muscle fibers in the relaxed state, rigor, and during contraction using fluorescent phalloidin. J Cell Biol 97: 1663-1667, 1983.
20. Shin S, Freedman VH, Risser R and Pollack R: Tumorigenicity of virus-transformed nude mice is correlated specifically with anchorage independent growth in vitro. Proc Natl Acad Sci USA 72: 4435-4439, 1975.
21. Nishida E and Gotoh Y: Mitogen-activated protein kinase and cytoskeleton in mitogenic signal transduction. Int Rev Cytol 138: 211-238, 1992.
22. Puck TT and Krystosek A: Role of the cytoskeleton in genome regulation and cancer. Int Rev Cytol 132: 75-108, 1992.
23. Puck TT and Krystosek A: Reverse transformation, genome, exposure and cancer. Adv Cancer Res 62: 125-151, 1992.
24. Vukicevic S, Latin V, Chen P, Batorsky R, Reddi AH and Sampath TK: Localization of osteogenic protein-1 (bone morphogenetic protein-7) during human embryonic development: high affinity binding to basement membranes. Biochem Biophys Res Commun 198: 693-700, 1994.
25. Eto Y, Tsuji T, Takezawa M, Takano S, Yokogawa Y and Shibai H: Purification and characterization of erythroid differentiation factor (EDF) isolated from human leukemia cell line THP-1. Biochem Biophys Res Commun 142: 1095-1103, 1987.
26. Yu J, Shao L, Lemas V, Vaughan J and Vale W: Importance of FSH-releasing protein and inhibin in erythrodifferentiation. Nature 330: 765-767, 1987.